Halofantrine hydrochloride is primarily used in the treatment of malaria, particularly for infections caused by Plasmodium falciparum, which is known for its resistance to other antimalarial drugs. It is effective in areas where chloroquine resistance is prevalent. The compound works by disrupting the parasite's ability to detoxify heme, leading to its accumulation and subsequent death of the parasite. However, due to its potential to cause serious cardiac side effects, such as arrhythmias, it is generally reserved for cases where other treatments have failed or are not suitable. It is administered orally and is often used in combination with other antimalarial agents to enhance efficacy and reduce the risk of resistance development. Careful monitoring of cardiac function is essential during its use.